Moderna coronavirus vaccine shows promising results in early clinical trial

An experimental coronavirus vaccine developed by Moderna provoked an immune response without major side effects in an early-stage clinical trial, scientists reported Tuesday in the New England Journal of Medicine. The Phase I trial, conducted in partnership with the U.S. National Institute of Allerg…